Previous Close | 0.6000 |
Open | 0.6000 |
Bid | 0.0000 |
Ask | 5.0000 |
Strike | 30.00 |
Expire Date | 2024-12-20 |
Day's Range | 0.6000 - 0.6000 |
Contract Range | N/A |
Volume | |
Open Interest | 6 |
Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition.
Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ Week event on September 16 - 20. GENEWIZ Week will showcase our commitment to providing cutting-edge solutions to researchers worldwide through a series of workshops, an awards program, and engaging prizes and promotions.
Azenta ( NASDAQ:AZTA ) Third Quarter 2024 Results Key Financial Results Revenue: US$172.8m (up 4.1% from 3Q 2023). Net...